| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B | $0.4B | $0.4B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.3B | $3.8B | $4.1B | $2.7B | $1.8B | $-2.4B | $-0.4B | $2.5B |
| Net Income | $1.3B | $2.5B | $2.6B | $1.6B | $1.5B | $-2.9B | $-1.1B | $1.7B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | $-1.29 | $1.89 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $25.0B | $25.6B | $24.7B | $23.3B | $22.3B | $20.7B | $25.4B | $26.0B |
| Current Assets | $11.4B | $12.4B | $11.5B | $11.0B | $9.9B | $9.5B | $11.2B | $11.2B |
| Cash & Equivalents | $2.2B | $2.6B | $2.3B | $2.3B | $3.0B | $2.6B | $2.3B | $2.0B |
| Total Liabilities | $14.5B | $15.0B | $15.3B | $15.3B | $15.6B | $15.7B | $17.4B | $16.4B |
| Current Liabilities | $5.6B | $6.0B | $5.6B | $5.3B | $4.3B | $4.4B | $4.9B | $4.8B |
| Stockholders' Equity | $10.5B | $10.5B | $9.4B | $7.9B | $6.7B | $5.0B | $8.0B | $9.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.9B | $3.9B | $3.5B | $2.2B | $1.9B | $1.9B | $2.4B | $3.2B |
| Investing Cash Flow | $-1.3B | $-1.7B | $-1.7B | $-1.0B | $-0.5B | $-0.5B | $-1.4B | $-2.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-2.0B | $-1.7B | $-1.7B | $-1.8B | $-0.8B | $-1.0B | $-0.7B | $-1.4B |